InvestorsObserver
×
News Home

Is SAGE Therapeutics Inc (SAGE) Stock Worth a Buy Wednesday?

Wednesday, August 12, 2020 02:29 PM | InvestorsObserver Analysts

Mentioned in this article

Is SAGE Therapeutics Inc (SAGE) Stock Worth a Buy Wednesday?

SAGE Therapeutics Inc (SAGE) stock has fallen -69.63% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives SAGE stock a score of 28 out of a possible 100.

That rank is mainly influenced by a short-term technical score of 3. SAGE's rank also includes a long-term technical score of 20. The fundamental score for SAGE is 61. In addition to the average rating from Wall Street analysts, SAGE stock has a mean target price of 69.611. This means analysts expect the stock to increase 38.45% over the next 12 months.

Overall Score - 28
SAGE has an Overall Score of 28. Find out what this means to you and get the rest of the rankings on SAGE!

What's Happening with SAGE Stock Today

SAGE Therapeutics Inc (SAGE) stock has fallen -2.12% while the S&P 500 has gained 1.32% as of 2:25 PM on Wednesday, Aug 12. SAGE has fallen -$1.09 from the previous closing price of $51.37 on volume of 515,334 shares. Over the past year the S&P 500 is higher by 15.43% while SAGE has fallen -69.63%. SAGE lost -$11.80 per share in the over the last 12 months.

Click Here to get the full Stock Score Report on SAGE Therapeutics Inc (SAGE) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App